Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Bullboard Posts
Post by cybermanon Sep 04, 2019 5:21pm
140 Views
Post# 30095942

there it is...

there it is...

Toronto, Ontario--(Newsfile Corp. - September 4, 2019) -  Osoyoos Cannabis Inc. (CSE: OSO) ("Osoyoos" or the "Company) wishes to announce that its letter of intent with Anahit International Corp. ("Anahit") as previously announced on May 16, 2019 (the "LOI") has been terminated. Pursuant to the LOI, Osoyoos and Anahit were to complete a business combination that would result in a reverse takeover of Osoyoos. Osoyoos and Anahit mutually agreed to terminate the LOI after concluding that the expected synergies of the transaction were unlikely to be realized. 

The Company has applied to the CSE to resume trading of its common shares, and expects that such approval will be granted shortly. The Company will issue a further press release upon receipt of CSE approval.

About Osoyoos Cannabis Inc.

Osoyoos Cannabis Inc. is an early-stage cannabinoid extraction company based in Oliver, BC. Osoyoos Cannabis has applied for a standard processing license under the Cannabis Act for its 10,410 ft2 facility and that application is currently in the review stage. The Company will offer contract tolling extraction, sale of bulk oil and development of both proprietary Osoyoos Cannabis branded and white labelled products once licensed to do so.

For further information, please contact:
Osoyoos Cannabis Inc.
Gerry Goldberg, Interim CEO 
Phone: (416) 460-3000

 


Read more at https://stockhouse.com/news/press-releases/2019/09/04/osoyoos-announces-termination-of-loi-with-anahit#0jvocughjFz82AHV.99
Bullboard Posts